Your invitation from the Bigpicture Project:  We are excited to invite you to the first Bigpicture Community Meeting, themed ‘The Digital Transformation of Pathology’. During the online meeting, Prof. Jeroen van der Laak, WP1 Bigpicture Project Coordinator, and Dr Julie Boisclair, WP1 EFPIA Lead, will explain the foundation of the Bigpicture project, and cover the […] The post Bigpicture Announces First Community Meeting in May first appeared on Tissuepathology.com ..read more

From the Aiosyn blog: In the ever-changing landscape of pathology, the accurate assessment of mitotic activity plays a crucial role in diagnosing and managing various diseases, including cancer. Traditionally, pathologists manually count mitotic figures under a microscope in a labor-intensive and time-consuming process that is highly prone to inter-observer variability. However, with the rapid development […] The post Aiosyn: The benefits of AI implementation in mitotic figure counting first appeared on Tissuepathology.com ..read more

CHICAGO–(BUSINESS WIRE)–Nucleai, a spatial AI biomarker company that deciphers cellular conversations and maps cellular interactions within tissue samples to predict therapeutic outcomes, today announced a strategic collaboration with GoPath Diagnostics, a leading full-service digital pathology and molecular diagnostics laboratory. This collaboration aims to offer AI-powered digital pathology solutions for clinical trials and diagnostics and foster innovative […] The post Nucleai and GoPath Diagnostics Announce Strategic Collaboration to Provide Integrated AI-powered Digital Pathology Sol ..read more

The Extension Funds Nucleai to Advance Its First-in-Class Spatial AI Biomarker in Active Clinical Enrollment Investment Expands Deployments of AI-Powered Spatial Biomarker Technology, Strengthening Companion Diagnostics for ADCs, Bi-specifics, and Immunotherapies M Ventures is the corporate strategic venture arm of Merck KGaA, Darmstadt, Germany April 03, 2024 07:00 AM Eastern Daylight Time CHICAGO–(BUSINESS WIRE)–Nucleai, a […] The post Merck’s Corporate Venture M Ventures Arm Backs Nucleai to Advance Its First-in-class Spatial AI Biomarker in Active Clinical Enrollment first appeared on Tiss ..read more

From the Lumea Podcast – Ask A Pathologist:  Welcome to our seventh episode of the Ask a Pathologist Podcast, Innovators in Action. We had the privilege to interview Dr. Todd Randolph about artificial intelligence and its current and future role in digital pathology. Dr. Todd Randolph holds board certification in anatomic pathology and cytopathology. He […] The post Lumea Podcast: Artificial Intelligence In Digital Pathology first appeared on Tissuepathology.com ..read more

Incyte: Pathology clinic installs ultra-fast slide scanners, prepares for AI future February 29, 2024 Karina Elias Diagnostic pathology clinic Incyte Diagnostics has installed two digital pathology slide scanners at its Spokane Valley laboratory, marking a stride toward enhancing the clinic’s services, says Incyte pathologist Dr. Isaac Grindeland. The two scanners are part of the Philips […] The post Incyte Diagnostics goes digital first appeared on Tissuepathology.com ..read more

Nijmegen, The Netherlands – Aiosyn, a pioneering medical software company specializing in AI-powered pathology solutions for cancer and kidney disease, has announced a partnership with Ziekenhuis aan de Stroom (ZAS) Netwerk, a collaboration of Ziekienhuizen Netwerk Antwerpen (ZNA) and GZA Ziekienhuizen. Both Belgian hospital groups are currently in a fusion traject which will make them one of the largest healthcare organizations […] The post ZAS Netwerk partners with Aiosyn to evaluate AI-powered mitosis detection in clinical settings first appeared on Tissuepatho ..read more

Gestalt: Revolutionizing Algorithm Assessment in Digital Pathology SPOKANE, Wash., March 22, 2024 /PRNewswire/ — Gestalt Diagnostics, Inc., a leading provider of (AI)-driven digital pathology solutions, is proud to announce the launch of its leading-edge AI Algorithm Evaluator. This groundbreaking, patent-pending tool empowers pathologists, researchers, and healthcare professionals to assess and compare the performance of AI algorithms with unprecedented precision […] The post Gestalt Announces PathFlow’s AI Algorithm Evaluator first appeared on Tissuepathology.com ..read more

Pramana: Over 6.5 Million Glass Slides Digitized in the Last 12 Months and 15 Billion Images Validated with Near-Perfect Accuracy Using Pramana’s Innovative In-Line Quality Assurance Algorithms CAMBRIDGE, Mass.–(BUSINESS WIRE)–Pramana, Inc., will showcase its suite of transformative solutions enabling Digital Pathology 2.0 at the USCAP annual conference in Baltimore, MD, March 25-28, 2024, at booth […] The post Pramana Achieves Industry-Leading Milestone with Digital Pathology 2.0 Technology first appeared on Tissuepathology.com ..read more

Evident Life Science on LinkedIn: We’re so excited to see the installation of CX23 microscopes at Kutztown University of Pennsylvania in Kutztown, PA. Focused on improving #workflow for educational #microscopy, the CX23 upright microscope’s minimal setup is why it’s the perfect microscope to have in the classroom. Learn more about the CX23 system ?? https://brnw.ch/21wHS1m […] The post Evident Life Science CX23 Microscopes at Kutztown University of Pennsylvania first appeared on Tissuepathology.com ..read more